E1208 A Phase III Randomized, Double-Blind Trial of Chemoembolization

E1208 A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion

Sponsor(s)

Frontier Science and Technology Research Foundation

Principal Investigator(s)John Kauh, MD
Dates3/16/2010 - 3/16/2014